- Home
- IMXI vs ORIC Comparison
IMXI vs ORIC Comparison
Compare IMXI & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMXI | ORIC |
|---|---|---|
| Founded | 1994 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 456.2M | 783.0M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IMXI | ORIC |
|---|---|---|
| Price | $15.42 | $8.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 12 |
| Target Price | $16.67 | ★ $19.50 |
| AVG Volume (30 Days) | 212.3K | ★ 1.4M |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | ★ $625,123,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.95 | N/A |
| P/E Ratio | $11.96 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.58 | $3.90 |
| 52 Week High | $21.41 | $14.93 |
Technical Indicators
Market Signals| Indicator | IMXI | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 27.80 |
| Support Level | $15.32 | $7.98 |
| Resistance Level | $15.42 | $8.62 |
| Average True Range (ATR) | 0.06 | 0.59 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 36.21 | 6.52 |
Price Performance
Historical ComparisonAbout IMXI International Money Express Inc.
International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.